Llew Keltner, Director at Raptor Pharmaceutical Corp (RPTP), sold 50,000 shares at $16.05 ($803K) on 2015-07-01, disclosed to the SEC on 2015-07-02.
Scheduled sale ($802k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RPTP | SELL | 2014-03-11 | $157K | — | Filing → |
| RPTP | SELL | 2014-01-09 | $133K | — | Filing → |
| RPTP | SELL | 2013-11-12 | $140K | — | Filing → |